SEC Form 4 · accession 0001179110-16-021749
Apollo Endosurgery, Inc. · APEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Ferrell
Director
Period of report
Mar 9, 2016
Accepted (ET)
Mar 16, 2016 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001251769
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 9, 2016 | M | 3,485 | — | A | 12,486 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2,F3 | — | Mar 9, 2016 | M | 3,485 | D | — | — | Common Stock | 3,485 | 0 | D |
Explanation of responses
- F1Represents a restricted stock unit previously reported as 24,390 shares as adjusted to reflect a 1-for-7 reverse stock split that occurred on October 8, 2012.
- F2The restricted stock unit represented a right to receive shares of the Issuer's common stock, subject to vesting requirements, at no additional conversion or exercise price.
- F325% of the Restricted Stock Units vested one year following the date of grant (March 9, 2011) and the remaining shares vested in 12 equal quarterly installments thereafter. Vested shares were delivered to the reporting person on the fifth anniversary of the date of grant.